PFE: Weekly Trendline Breakout + Strong Monthly Support ReboundOverview:
I am looking at a bullish reversal setup for Pfizer (PFE). The stock has been in a long-term consolidation phase and is now showing signs of a strong trend shift across multiple timeframes.
1. Monthly Timeframe (The Foundation):
As seen in the image, PFE has arrived at a major long-ter
Key facts today
Pfizer says Chief Strategy and Innovation Officer Andrew Baum will shift to senior strategic advisor to CEO, cut daily duties, and likely exit by year-end while aiding high-level strategy.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.36 USD
7.77 B USD
62.58 B USD
5.68 B
About Pfizer, Inc.
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
IPO date
Jan 17, 1944
Identifiers
3
ISIN US7170811035
Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Related stocks
Pfizer Wave Analysis – 2 April 2026
- Pfizer broke resistance zone
- Likely to rise to resistance level 29.50
Pfizer recently broke the resistance zone between the resistance trendline of the daily Triangle from the start of February and the resistance level 27.6 (former multi-month high from October).
The breakout of this resista
PFE - Pfizer: Investment Analysis Thoughts1️⃣ The world is in a state of permanent turbulence
After COVID, one thing became clear:
global systems can quickly shift into fear, uncertainty, and bio-risk mode.
Epidemics are no longer seen as something distant — the market is psychologically prepared for new waves.
➡️ For an investor, the key
Pfizer Breakout OpportunityNYSE:PFE Trade Overview: Pfizer (PFE) Long
I am executing a short-term swing trade based on a combination of technical patterns and momentum indicators, looking for a breakout above key resistance.
Technical Setup
Strategy: Short-term swing (2–15 day hold) using timeframe alignment.
Primary Signa
US – S&P 500 | Pfizer Inc. | Structural CensusPfizer experienced a powerful secular advance into the late-1990s, culminating in a major structural peak.
Since then, the stock has largely oscillated within a broad multi-decade range, reflecting a Complex / Range Structure rather than sustained directional expansion.
Part of the ongoing S&P 500
RECAP - Generating Extra Income with Pfizer StockFor income-focused investors, the pursuit of consistent returns often leads to a combination of two distinct yet complementary strategies: investing in blue-chip, high-dividend stocks and utilizing options trading to generate additional premium income. Among the most accessible and popular options s
Pfizer Weekly: Selling Into Obesity‑Hype ResistancePfizer (PFE) is pushing into weekly resistance after an obesity‑pipeline bounce, but the long‑term trend and post‑COVID overhang keep the broader structure heavy, so I’m treating this move as a place to sell rather than chase.
My plan is to use this zone to enter/hold shorts with stops beyond the r
Pfizer (PFE): Undervalued Pharma Giant Amid #Economy Resilience?Pfizer (PFE): Undervalued Pharma Giant Amid #Economy Resilience? $28.90 in Sight? 📈
At $24.04 (+0.04%), PFE offers a compelling entry with its low P/E of 12.72 and robust 7.15% dividend yield, trading well below analyst targets of $28.90 (20% upside potential)—could resilient economic forecasts boo
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of PFE is 27.52 USD — it has decreased by −0.15% in the past 24 hours. Watch Pfizer, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Pfizer, Inc. stocks are traded under the ticker PFE.
PFE stock has risen by 2.57% compared to the previous week, the month change is a 0.40% rise, over the last year Pfizer, Inc. has showed a 24.24% increase.
We've gathered analysts' opinions on Pfizer, Inc. future price: according to them, PFE price has a max estimate of 36.00 USD and a min estimate of 25.00 USD. Watch PFE chart and read a more detailed Pfizer, Inc. stock forecast: see what analysts think of Pfizer, Inc. and suggest that you do with its stocks.
PFE stock is 1.22% volatile and has beta coefficient of 0.61. Track Pfizer, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pfizer, Inc. there?
Today Pfizer, Inc. has the market capitalization of 156.54 B, it has increased by 0.80% over the last week.
Yes, you can track Pfizer, Inc. financials in yearly and quarterly reports right on TradingView.
Pfizer, Inc. is going to release the next earnings report on May 5, 2026. Keep track of upcoming events with our Earnings Calendar.
PFE earnings for the last quarter are 0.66 USD per share, whereas the estimation was 0.57 USD resulting in a 16.43% surprise. The estimated earnings for the next quarter are 0.72 USD per share. See more details about Pfizer, Inc. earnings.
Pfizer, Inc. revenue for the last quarter amounts to 17.56 B USD, despite the estimated figure of 16.85 B USD. In the next quarter, revenue is expected to reach 13.82 B USD.
PFE net income for the last quarter is −1.65 B USD, while the quarter before that showed 3.54 B USD of net income which accounts for 0.00% change. Track more Pfizer, Inc. financial stats to get the full picture.
Yes, PFE dividends are paid quarterly. The last dividend per share was 0.43 USD. As of today, Dividend Yield (TTM)% is 6.25%. Tracking Pfizer, Inc. dividends might help you take more informed decisions.
Pfizer, Inc. dividend yield was 6.91% in 2025, and payout ratio reached 126.85%. The year before the numbers were 6.37% and 120.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 21, 2026, the company has 75 K employees. See our rating of the largest employees — is Pfizer, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pfizer, Inc. EBITDA is 24.11 B USD, and current EBITDA margin is 37.87%. See more stats in Pfizer, Inc. financial statements.
Like other stocks, PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pfizer, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pfizer, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pfizer, Inc. stock shows the sell signal. See more of Pfizer, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









